How Bhattacharya’s NIH Is Rethinking China, DEI, and High‑Risk Labs

NIH Rethinking China, DEI, and High-Risk Labs

The NIH director outlines efforts to reform the agency-largest public funder of biomedical research.

How Bhattacharya’s NIH Is Rethinking China, DEI, and High‑Risk Labs

For decades, scientists have looked at the National Institutes of Health (NIH) as an agency that publishes papers, according to Dr. Jay Bhattacharya. Under President Donald Trump’s second term, the emphasis for NIH funding has shifted to “provable, testable hypotheses, not ideological narratives,” he said, which is resulting in widespread reforms to the agency. Bhattacharya, who obtained both a doctorate in economics and a medical degree from St…